Detalhe da pesquisa
1.
Antinuclear antibody-associated autoimmune cytopenia in childhood is a risk factor for systemic lupus erythematosus.
Blood
; 143(16): 1576-1585, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38227934
2.
Determinants of long-term outcomes of splenectomy in pediatric autoimmune cytopenias.
Blood
; 140(3): 253-261, 2022 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35443028
3.
Pediatric refractory chronic immune thrombocytopenia: Identification, patients' characteristics, and outcome.
Am J Hematol
; 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38651646
4.
Impact of age at diagnosis, sex, and immunopathological manifestations in 886 patients with pediatric chronic immune thrombocytopenia.
Am J Hematol
; 98(6): 857-868, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36882195
5.
Long term follow-up of pediatric-onset Evans syndrome: broad immunopathological manifestations and high treatment burden.
Haematologica
; 107(2): 457-466, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33440924
6.
PIEZO1-gene gain-of-function mutations with lower limb lymphedema onset in an adult: Clinical, scintigraphic, and noncontrast magnetic resonance lymphography findings.
Am J Med Genet A
; 188(1): 243-248, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34477311
7.
Improved stenosis outcome in stroke-free sickle cell anemia children after transplantation compared to chronic transfusion.
Br J Haematol
; 193(1): 188-193, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33216975
8.
Prospective Evaluation of the First Option, Second-Line Therapy in Childhood Chronic Immune Thrombocytopenia: Splenectomy or Immunomodulation.
J Pediatr
; 231: 223-230, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33340549
9.
Recent advances in the pathophysiology of PIEZO1-related hereditary xerocytosis.
Am J Hematol
; 96(8): 1017-1026, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33848364
10.
Second-line treatment trends and long-term outcomes of 392 children with chronic immune thrombocytopenic purpura: the French experience over the past 25 years.
Br J Haematol
; 189(5): 931-942, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32130726
11.
PIEZO1 activation delays erythroid differentiation of normal and hereditary xerocytosis-derived human progenitor cells.
Haematologica
; 105(3): 610-622, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31413092
12.
Appropriate thresholds for accurate screening for ß-thalassemias in the newborn period: results from a French center for newborn screening.
Clin Chem Lab Med
; 59(1): 209-216, 2020 08 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32813673
13.
Clinical and biological features in PIEZO1-hereditary xerocytosis and Gardos channelopathy: a retrospective series of 126 patients.
Haematologica
; 104(8): 1554-1564, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30655378
14.
Association of Matched Sibling Donor Hematopoietic Stem Cell Transplantation With Transcranial Doppler Velocities in Children With Sickle Cell Anemia.
JAMA
; 321(3): 266-276, 2019 01 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30667500
15.
Delayed hemolytic transfusion reaction in children with sickle cell disease: first 5-year retrospective study in mainland France.
Haematologica
; 108(3): 889-894, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36325889
16.
Prognostic factors of disease severity in infants with sickle cell anemia: A comprehensive longitudinal cohort study.
Am J Hematol
; 93(11): 1411-1419, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30132969
17.
Severe cases of COVID-19 in children with sickle cell disease during the Omicron wave in France: a plea for vaccination.
Br J Haematol
; 199(2): e8-e11, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35993188
18.
Benefits of rituximab as a second-line treatment for autoimmune haemolytic anaemia in children: a prospective French cohort study.
Br J Haematol
; 177(5): 751-758, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28444729
19.
A mutation in the Gardos channel is associated with hereditary xerocytosis.
Blood
; 126(11): 1273-80, 2015 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26148990
20.
Risk factors for severe COVID-19 in hospitalized sickle cell disease patients: A study of 319 patients in France.
Am J Hematol
; 97(3): E86-E91, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34882837